Table 5.

Risk factors for the flare of FMF attacks after COVID-19.

	OR	95% CI lower	95% CI upper	p value
Male gender	0.902	0. 303	2.690	.854
Age	0.989	0.948	1.031	.595
Comorbidity	1.444	0.516	4.043	.484
M694V mutation	0.711	0.192	2.630	.609
Active disease before the infection	7.286	2.328	22.805	.001
Dose of colchicine treatment
1 mg/day	0.614	0.209	1.803	.375
1.5 mg/day	0.725	0.235	2.236	.576
2 mg/day	0.321	0.102	1.008	.052
Use of IL-1 antagonists	0.214	0.044	1.047	.057
Colchicine non-adherence before the infection	0.371	0.041	2.291	.380
Outcomes
Hospitalization	1.275	0.394	4.123	.685
Respiratory support	1.579	0.321	7.769	.574